U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Despite the Centers for Disease Control and Prevention's recommendations, vaccine rates against COVID-19, RSV, and the flu ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

In addition to vaccinations, Shah emphasizes the importance of avoiding gatherings when you do not feel well and shares an ...

Adults 18-60 may not get severe RSV, but they can still contract it. Learn the symptoms of adult RSV, when to see a doctor, ...

GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV ...

A new survey from The National Foundation for Infectious Diseases found fewer than 1 in 5 U.S. adults are concerned about flu ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...